Nimotuzumab

Embed this Topic
A humanized monoclonal antibody directed against the epidermal growth factor receptor (EGFR) with potential antineoplastic activity. Nimotuzumab binds to and inhibits EGFR, resulting in growth inhibition of tumor cells that overexpress EGFR. This agent may act synergistically with radiation therapy.

Medicine

CAS Number:

  • 828933-51-3

Drug class:

Brands:

View entire collection »

Route of administration:

Trials:

View entire collection »

Used To Treat:

top ↑

Facts from the Community

From the BioVenturist base

Technology involved:

View entire collection »

Developed by:

Brand Names:

  • Theraloc
  • BIOMAb EGFR
  • CIMAher
  • TheraCIM

Stage of development:

Target/Biomolecule of Interest:

therapeutic molecule:

top ↑

Similar topics in Freebase

  • SGN-40

  • SGN-75

  • Apolizumab

    Apolizumab is a humanized monoclonal antibody that is being studied as a treatment for hematologic cancers.

  • Palivizumab

    Palivizumab (brand name Synagis or Abbosynagis) is a monoclonal antibody produced by recombinant DNA technology. It is used in the prevention of Respiratory Syncytial Virus (RSV) infections. It is recommended for certain infants that are high-risk (because of prematurity or other medical problems),...

  • Panitumumab

    Panitumumab (INN), formerly ABX-EGF, is a fully human monoclonal antibody specific to the epidermal growth factor receptor (also known as EGF receptor, EGFR, ErbB-1 and HER1 in humans). Panitumumab is manufactured by Amgen and marketed as Vectibix. It was approved by the U.S. Food and Drug...

  • Cetuximab

    Cetuximab (IMC-C225 -- marketed under the name Erbitux) is a chimeric (mouse/human) monoclonal antibody, an epidermal growth factor receptor (EGFR) inhibitor, given by intravenous infusion for treatment of metastatic colorectal cancer and head and neck cancer. This agent is based on Dr. John...

These people have edited this topic:

  • bgood
Edit this topic
Edit and Show details

Add or delete facts, download data in JSON or RDF formats, and explore topic metadata.

Freebase Logo
What is Freebase?

Freebase is a huge collection of facts, built by people like you. Freebase connects facts in ways other sites can't, giving you new ways to explore millions of subjects.
You can help improve it!

Freebase Attribution

Freebase data is free for use under the CC-BY license.

The original description for Nimotuzumab was automatically generated from Wikipedia.org licensed under the GNU Free Documentation License.
[1]
Learn more about Freebase licensing and attribution